Form 4: Curis Inc. CFO Diantha Duvall Reports Stock Option Grant
SEC Filing Form 4
Diantha Duvall, CFO of Curis Inc., reports the acquisition of stock options in the company.
Summary
- Diantha Duvall, the CFO of Curis Inc. (CRIS), filed a Form 4 with the SEC.
- The filing reports a transaction involving derivative securities.
- Specifically, Duvall acquired an employee stock option (right to buy) 15,000 shares of Curis Inc. common stock at an exercise price of $3.13 on January 28, 2025.
- The options vest as to 25% of the original shares on January 28, 2026, and then 6.25% each quarter until January 28, 2029.
- Following the reported transaction, Duvall directly owns 15,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to executive compensation, and does not contain information that would significantly shift investor sentiment.
Positives
- The grant of stock options to the CFO could align her interests with those of the shareholders, incentivizing her to improve the company's performance.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- The stock option grant could potentially benefit shareholders if it incentivizes the CFO to improve company performance.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of the stock option grant. |
| 01/28/2026 | First vesting date for 25% of the stock options. |
| 01/28/2029 | Final vesting date for the stock options. |
| 01/27/2035 | Expiration date of the stock options. |
| 01/30/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.